such hybrid molecules. Because of the dual specificity of these hybrids, they were appropriately named "bi-specific" (Milstein and Cuello, 1983, 1984) . Bi-specific monoclonal antibodies (MAb) have been produced by the in vivo technique and found capable of simultaneous recognition of tissue antigens and an enzymatic marker (Suresh et al., 1986; Milstein and Cuello, 1983 et al., 1985; Cuello et al., 1984; MacMillan et al., 1984; Mason et al., 1982) , such as the three-step penoxidase-antipenoxidase (PAP) procedure (Stennberger et al., 1970) (Spitz et al., 1984) . The dose of the antigen administered intrasplenically was the same as in the previous immunizations.
Cell Fusion
Fusions were carried out essentially as described in the method of Kohler and Milstein (1975, 1976) , with the following modification: the aminoptenin- After fixation, the spinal cord was removed and 50-tm sections were generated with the use ofa sliding microtome. The sections were processed free-floating as follows: first incubation with the primary antibody was allowed to proceed overnight at 4'C, fol- as well as its varicosities, in this 50-aim preparation ( Figure   4 ). In addition, the use ofthese bi-specific MAb in an in vitro prepanation ( Figure  5 ), using rabbit anti-GFAP as the primary antibody, revealed the well-established GFAP immunoreactivity in the astroglia (Bignami et al., 1972) . Background staining was again absent.
McC8 was used and compared to the conventional PAP proce- (Meijen et al., 1986; Watkins, 1977) . 
